Alcohol Medication Essay

1458 Words3 Pages

FDA Approved Medications for the Treatment of Alcohol Dependence The toxic element in alcohol is ethanol (Nutt, 2006). The five major neurotransmitter systems within the brain that are affected by alcohol are glutamate, gamma-amino-butyric acid (GABA), dopamine, serotonin and the opioid systems (Chastain, 2006; Prince & Turpin, 2008). Intoxication, memory impairment, reinforcement and dependence are some of the effects produced as a result of ethanol modifying neural functions (Chastain, 2006). The pleasurable effects of alcohol are partly due to the increased central inhibition caused by the agonist effect ethanol has on GABA-A as well as the antagonist effect ethanol has on the NMDA glutamate receptors resulting in reduced central excitation (Nutt, 2006; Weaver, Jewell & Tomlinson, 2009). The pleasurable effects may also be linked to interactions between alcohol and endogenous opioids, dopamine, and serotonin (Chastain, 2006; Nutt, 2006). The rewarding effects of alcohol may contribute to alcohol dependence. When alcohol is used frequently over a long period of time the inhibitory processes in the brain are reduced and the excitatory processes are enhanced and when alcohol is not present symptoms of alcohol withdrawal may occur (Barrons & Roberts, 2010; Prince & Turpin, 2008; Weaver et al., 2009). Consuming alcohol may relieve these symptoms which might also contribute to alcohol dependence. In addition, genetic, psychosocial and environmental factors can contribute to whether or not an individual is at a higher risk of developing alcohol dependence (Angelini & Brahmbhatt, 2007). Approximately 20% of hospital admissions are linked to alcohol dependence (Barrons & Roberts, 2010; Muzyk, Leung, Nelson, Embury & Jones, 2013). The m... ... middle of paper ... ...l ingested by those who continue to drink while on medication (Angelini & Brahmbhatt, 2007; Lingford-Hughes et al., 2004). It is suggested that naltrexone may be more useful than acamprosate or disulfiram for those who are still drinking alcohol but have the desire to stop (Lingford-Hughes et al., 2004). Acamprosate can also continue to be used if someone starts drinking again as it has also been shown to reduce the amount of alcohol ingested (Lingford-Hughes et al., 2004). According to Lingford-Hughes et al. (2004), neither naltrexone nor acamprosate have been shown to be more effective than the other in treating alcohol dependence. No consistent evidence exists regarding which types of patients will respond better to acamprosate or naltrexone so both should be considered equally as options for those wishing to abstain from alcohol (Lingford-Hughes et al., 2004).

Open Document